GLP-1 drugs: what Medi-Cal paid

Q: Does a paid prescription mean Medi-Cal covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Medi-Cal shows a published payment figure for 8 of the 8 GLP-1 products this site tracks, in the latest federal quarter. A paid prescription records what happened and is not permission for what happens next, so read the figures below as a payment history rather than as a coverage rule.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Medi-Cal’s payment record shows

In 2026Q1, the product Medi-Cal paid for most often was Ozempic®, at 205,731 prescriptions¹⁹ of the 473,171 to 473,288^{1,7,13,19,25,31,37,43} across all 8 products, or 43 percent of the published count.

Medi-Cal itself reimbursed at least $502,053,514 for these products in the quarter, about $1,061 per prescription. Pharmacies were paid $512,866,012 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Rybelsus®, at about $1,501.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Medi-Cal finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Medi-Cal. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Medi-Cal paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Medi-Cal paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Both134 managed care, 62,286 direct	62,420¹	13%	$65,538,392	$66,160,150	$1,050
tirzepatideMounjaro®	Both401 managed care, 116,615 direct	117,016⁷	25%	$122,991,035	$126,103,513	$1,051
semaglutideWegovy®	Both165 managed care, 63,947 direct	at least 64,112¹³	14%	$83,506,483	$84,077,430	$1,303
semaglutideOzempic®	Both721 managed care, 205,010 direct	205,731¹⁹	43%	$198,095,326	$204,283,746	$963
semaglutideRybelsus®	Both199 managed care, 19,500 direct	19,699²⁵	4%	$29,566,793	$29,805,311	$1,501
liraglutideSaxenda®	Both	380³¹	<1%	$459,904	$460,695	$1,210
liraglutideVictoza®	Both	2,255³⁷	<1%	$1,417,399	$1,417,875	$629
liraglutideliraglutide (generic)	Both20 managed care, 1,525 direct	at least 1,545⁴³	<1%	$478,181	$557,292	$310

Medi-Cal publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were higher in 2026Q1 than in 2021Q1: 22,334 against 13,134. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 42.3 prescriptions per thousand people enrolled in Medi-Cal, on an average of 11,178,145 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 1 of the 168 product-quarters it holds a row for here, which is 1 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic®, Rybelsus®, Saxenda® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Medi-Cal pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Medi-Cal paid for each product, quarter by quarter

Prescriptions Medi-Cal paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®range 9,771 to 62,420	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	at least 26 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴At least$25,270 paid	9,771 paid prescriptions in the quarter (2024Q1)³Count$10,345,028 paid	15,119 paid prescriptions in the quarter (2024Q2)³Count$15,747,765 paid	27,641 paid prescriptions in the quarter (2024Q3)³Count$28,709,318 paid	at least 50,086 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³At least$51,019,112 paid	at least 93,284 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$96,845,034 paid	at least 120,953 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$126,272,652 paid	at least 235,411 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$247,319,273 paid	at least 252,179 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$265,023,320 paid	62,420 paid prescriptions in the quarter (2026Q1)¹Count$65,538,392 paid
tirzepatideMounjaro®range 29,932 to 117,016, up 26,356 on the quarter before	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	at least 1,690 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$1,909,302 paid	at least 4,151 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$4,296,756 paid	at least 8,649 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$9,117,956 paid	at least 10,399 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$11,189,815 paid	at least 16,472 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$17,948,534 paid	at least 18,187 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$19,913,107 paid	at least 22,655 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$25,592,857 paid	at least 21,307 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$23,935,090 paid	36,665 paid prescriptions in the quarter (2024Q3)⁹Count$41,187,702 paid	33,144 paid prescriptions in the quarter (2024Q4)⁹Count$37,029,832 paid	29,932 paid prescriptions in the quarter (2025Q1)⁸Count$31,442,571 paid	36,562 paid prescriptions in the quarter (2025Q2)⁸Count$37,689,478 paid	76,381 paid prescriptions in the quarter (2025Q3)⁸Count$78,477,839 paid	90,660 paid prescriptions in the quarter (2025Q4)⁸Count$93,502,409 paid	117,016 paid prescriptions in the quarter (2026Q1)⁷Count$122,991,035 paid
semaglutideWegovy®range 930 to 308,846	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q2)every reporting cell was withheld, so nothing is observable¹⁸Withheld2 of 2 product codes withheld	at least 206 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld¹⁸At least$263,365 paid	930 paid prescriptions in the quarter (2021Q4)¹⁸Count$1,169,814 paid	at least 2,316 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld¹⁷At least$3,249,217 paid	at least 4,723 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld¹⁷At least$6,512,152 paid	at least 4,430 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹⁷At least$6,372,625 paid	at least 3,986 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹⁷At least$5,776,956 paid	at least 23,297 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁶At least$31,894,555 paid	at least 52,052 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁶At least$69,440,334 paid	at least 59,563 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁶At least$80,073,940 paid	at least 45,178 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁶At least$59,426,985 paid	at least 55,353 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld¹⁵At least$71,675,696 paid	at least 85,979 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld¹⁵At least$111,631,505 paid	at least 197,949 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$257,591,087 paid	185,814 paid prescriptions in the quarter (2024Q4)¹⁵Count$241,991,867 paid	214,640 paid prescriptions in the quarter (2025Q1)¹⁴Count$279,313,955 paid	207,648 paid prescriptions in the quarter (2025Q2)¹⁴Count$270,550,631 paid	308,846 paid prescriptions in the quarter (2025Q3)¹⁴Count$402,561,638 paid	269,170 paid prescriptions in the quarter (2025Q4)¹⁴Count$351,085,998 paid	at least 64,112 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$83,506,483 paid
semaglutideOzempic®range 24,695 to 268,427, down 11,025 on the quarter before	at least 17,872 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$17,149,305 paid	at least 20,766 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$19,933,134 paid	at least 23,740 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$22,723,977 paid	at least 26,652 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$25,405,393 paid	24,695 paid prescriptions in the quarter (2022Q1)²³Count$25,399,001 paid	at least 37,320 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$39,309,116 paid	at least 59,548 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$62,878,494 paid	at least 55,368 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$57,101,718 paid	at least 77,902 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$80,743,250 paid	at least 89,301 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$93,297,329 paid	162,419 paid prescriptions in the quarter (2023Q3)²²Count$164,980,512 paid	at least 144,072 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$144,747,279 paid	at least 181,343 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$187,616,279 paid	at least 182,763 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$191,118,959 paid	at least 257,767 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$268,504,317 paid	at least 229,383 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$235,986,661 paid	at least 229,589 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$215,000,217 paid	at least 200,312 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$189,228,115 paid	268,427 paid prescriptions in the quarter (2025Q3)²⁰Count$253,806,126 paid	216,756 paid prescriptions in the quarter (2025Q4)²⁰Count$205,165,783 paid	205,731 paid prescriptions in the quarter (2026Q1)¹⁹Count$198,095,326 paid
semaglutideRybelsus®range 2,211 to 30,621, down 759 on the quarter before	2,211 paid prescriptions in the quarter (2021Q1)³⁰Count$2,030,961 paid	3,548 paid prescriptions in the quarter (2021Q2)³⁰Count$3,307,844 paid	4,797 paid prescriptions in the quarter (2021Q3)³⁰Count$4,615,498 paid	5,663 paid prescriptions in the quarter (2021Q4)³⁰Count$5,398,746 paid	at least 6,846 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$7,373,302 paid	at least 12,018 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$12,582,803 paid	18,180 paid prescriptions in the quarter (2022Q3)²⁹Count$19,693,306 paid	17,631 paid prescriptions in the quarter (2022Q4)²⁹Count$19,609,010 paid	23,381 paid prescriptions in the quarter (2023Q1)²⁸Count$27,703,393 paid	21,214 paid prescriptions in the quarter (2023Q2)²⁸Count$26,007,271 paid	30,485 paid prescriptions in the quarter (2023Q3)²⁸Count$38,138,369 paid	25,241 paid prescriptions in the quarter (2023Q4)²⁸Count$32,678,516 paid	26,753 paid prescriptions in the quarter (2024Q1)²⁷Count$36,104,970 paid	at least 24,205 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$33,028,170 paid	30,621 paid prescriptions in the quarter (2024Q3)²⁷Count$42,707,734 paid	25,098 paid prescriptions in the quarter (2024Q4)²⁷Count$35,240,341 paid	22,585 paid prescriptions in the quarter (2025Q1)²⁶Count$32,217,819 paid	18,009 paid prescriptions in the quarter (2025Q2)²⁶Count$25,579,580 paid	24,453 paid prescriptions in the quarter (2025Q3)²⁶Count$34,954,443 paid	20,458 paid prescriptions in the quarter (2025Q4)²⁶Count$29,676,743 paid	19,699 paid prescriptions in the quarter (2026Q1)²⁵Count$29,566,793 paid
liraglutideSaxenda®range 380 to 14,402	1,581 paid prescriptions in the quarter (2021Q1)³⁶Count$1,968,544 paid	1,718 paid prescriptions in the quarter (2021Q2)³⁶Count$2,187,265 paid	1,961 paid prescriptions in the quarter (2021Q3)³⁶Count$2,442,916 paid	1,968 paid prescriptions in the quarter (2021Q4)³⁶Count$2,445,646 paid	1,875 paid prescriptions in the quarter (2022Q1)³⁵Count$2,472,413 paid	3,432 paid prescriptions in the quarter (2022Q2)³⁵Count$4,440,104 paid	7,969 paid prescriptions in the quarter (2022Q3)³⁵Count$10,336,722 paid	10,506 paid prescriptions in the quarter (2022Q4)³⁵Count$13,582,148 paid	14,402 paid prescriptions in the quarter (2023Q1)³⁴Count$18,665,082 paid	10,406 paid prescriptions in the quarter (2023Q2)³⁴Count$13,537,029 paid	14,282 paid prescriptions in the quarter (2023Q3)³⁴Count$17,676,238 paid	4,384 paid prescriptions in the quarter (2023Q4)³⁴Count$5,340,706 paid	at least 2,626 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³³At least$3,207,828 paid	at least 2,691 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³³At least$3,273,389 paid	at least 4,688 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³³At least$5,719,585 paid	at least 4,962 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³³At least$5,952,752 paid	at least 4,169 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³²At least$4,987,568 paid	at least 2,478 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld³²At least$2,990,740 paid	at least 2,555 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld³²At least$3,122,088 paid	at least 1,666 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld³²At least$2,039,925 paid	380 paid prescriptions in the quarter (2026Q1)³¹Count$459,904 paid
liraglutideVictoza®range 363 to 9,839, up 1,437 on the quarter before	9,342 paid prescriptions in the quarter (2021Q1)⁴²Count$7,685,202 paid	9,839 paid prescriptions in the quarter (2021Q2)⁴²Count$8,152,864 paid	9,820 paid prescriptions in the quarter (2021Q3)⁴²Count$7,973,750 paid	8,993 paid prescriptions in the quarter (2021Q4)⁴²Count$7,179,288 paid	7,671 paid prescriptions in the quarter (2022Q1)⁴¹Count$7,726,499 paid	8,761 paid prescriptions in the quarter (2022Q2)⁴¹Count$9,127,023 paid	at least 10,412 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld⁴¹At least$11,078,563 paid	8,477 paid prescriptions in the quarter (2022Q4)⁴¹Count$9,154,371 paid	at least 10,071 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld⁴⁰At least$11,116,805 paid	at least 8,207 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld⁴⁰At least$9,178,652 paid	at least 10,342 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld⁴⁰At least$11,517,656 paid	at least 7,885 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴⁰At least$8,561,575 paid	at least 7,423 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³⁹At least$6,155,877 paid	at least 6,071 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³⁹At least$4,452,839 paid	at least 5,785 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³⁹At least$4,017,324 paid	at least 4,486 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³⁹At least$3,167,360 paid	2,090 paid prescriptions in the quarter (2025Q1)³⁸Count$1,282,887 paid	363 paid prescriptions in the quarter (2025Q2)³⁸Count$239,581 paid	591 paid prescriptions in the quarter (2025Q3)³⁸Count$387,975 paid	818 paid prescriptions in the quarter (2025Q4)³⁸Count$555,078 paid	2,255 paid prescriptions in the quarter (2026Q1)³⁷Count$1,417,399 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	at least 385 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$149,963 paid	at least 417 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$218,193 paid	at least 1,402 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$601,937 paid	at least 2,155 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$912,874 paid	at least 3,427 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$1,341,638 paid	at least 2,726 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$989,413 paid	at least 1,545 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$478,181 paid

What Medi-Cal publishes as the rule

The figures above are payments. The rule that decides the next request is a different document, and where this site has read it the jurisdiction page carries it with the quote. Read the Medi-Cal coverage page.

Open California in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, CA
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state CA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "13694"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, CA
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state CA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "61455"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, CA
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state CA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "18343"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, CA
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state CA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "26"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, CA
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state CA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "product_name": "product_name like ZEPBOUND%, state CA, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, CA
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state CA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "product_name": "product_name like ZEPBOUND%, state CA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, CA
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state CA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "28279"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, CA
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state CA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "22973"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, CA
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state CA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "9823"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, CA
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state CA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "5390"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, CA
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state CA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1561"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, CA
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state CA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "product_name": "product_name like MOUNJARO%, state CA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, CA
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state CA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "21618"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, CA
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state CA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "82368"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, CA
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state CA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "53531"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, CA
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state CA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "22528"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, CA
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state CA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2022", "quarter": "3", "utilization_type": "FFSU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "2658"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, CA
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state CA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "280"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, CA
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state CA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "80499"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, CA
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state CA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "94711"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, CA
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state CA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "107729"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, CA
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state CA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2023", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "87449"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, CA
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state CA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2022", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "37035"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, CA
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state CA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "13585"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, CA
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state CA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "7753"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, CA
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state CA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "9478"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, CA
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state CA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "13102"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, CA
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state CA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2023", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "13769"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, CA
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state CA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2022", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "8214"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, CA
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state CA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "1951"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, CA
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state CA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "380"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, CA
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state CA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "4169"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, CA
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state CA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "4962"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, CA
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state CA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2023", "quarter": "1", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "14402"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, CA
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state CA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "10476"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, CA
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state CA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "1716"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, CA
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state CA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "1477"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, CA
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state CA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "1445"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, CA
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state CA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "3937"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, CA
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state CA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2023", "quarter": "3", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "5496"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, CA
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state CA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2022", "quarter": "3", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "5778"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, CA
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state CA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2021", "quarter": "2", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "3939"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, CA
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state CA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "827"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, CA
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state CA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "2051"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, CA
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state CA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "217"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, CA
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state CA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "product_name": "product_name like LIRAGLUTID%, state CA, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, CA
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state CA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "product_name": "product_name like LIRAGLUTID%, state CA, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, CA
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state CA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CA", "product_name": "product_name like LIRAGLUTID%, state CA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 42 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 6 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Medi-Cal covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.